Population-level indirect effects of HPV vaccination in high-income settings: a Bayesian modelling study

Background Human papillomavirus (HPV) vaccination provides direct protection to vaccinated individuals, but also indirectly protects unvaccinated individuals through reduced HPV transmission. Mechanistic transmission models that predict the magnitude of such effects have been crucial to informing vaccination strategies. However, nearly two decades of post-vaccination experience in high-income countries now allow us to empirically characterise how population-level indirect effects vary with vaccine coverage, time since vaccine introduction, and age. Methods We synthesised studies reporting HPV16/18 prevalence before and after vaccine introduction in high-income settings between 2007 and 2025. Indirect effects were estimated as the observed reduction in HPV16/18 prevalence after accounting for expected direct vaccine protection. We used a Bayesian hierarchical model to examine associations with vaccine coverage, time since vaccine introduction, and age at effect assessment across routine, catch-up, and non-targeted vaccination groups. XGBoost was used as a complementary, non-parametric approach. Findings Data from 11 high-income settings were included. Indirect effects increased during the first five to eight years after vaccine introduction and then remained relatively stable. Indirect effects generally decreased with increasing vaccine coverage. Patterns with age differed across vaccination groups. In the routine group, indirect effects increased during adolescence and remained positive at older observed ages. In the catch-up group, indirect effects decreased with age and approached zero or became negative after approximately age 25 years. XGBoost identified similar non-linear patterns. Interpretation Indirect protection against HPV16/18 develops gradually after vaccine introduction and varies with vaccine coverage, age, and vaccination group. This empirical approach can complement transmission models by using real-world evidence to characterise population-level indirect protection. However, making predictions outside the populations and ranges represented in the data should be done cautiously.

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2026-11-16
DOI
https://doi.org/10.64898/2026.11.13.26367966
Primary Topic
Cervical Cancer and HPV Research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Population-level indirect effects of HPV vaccination in high-income settings: a Bayesian modelling study

Mark Jit, Runze Wang
medRxiv
Cervical Cancer and HPV Research
preprint

Population-level indirect effects of HPV vaccination in high-income settings: a Bayesian modelling study

Mark Jit, Runze Wang
preprint en

Abstract

Background Human papillomavirus (HPV) vaccination provides direct protection to vaccinated individuals, but also indirectly protects unvaccinated individuals through reduced HPV transmission. Mechanistic transmission models that predict the magnitude of such effects have been crucial to informing vaccination strategies. However, nearly two decades of post-vaccination experience in high-income countries now allow us to empirically characterise how population-level indirect effects vary with vaccine coverage, time since vaccine introduction, and age. Methods We synthesised studies reporting HPV16/18 prevalence before and after vaccine introduction in high-income settings between 2007 and 2025. Indirect effects were estimated as the observed reduction in HPV16/18 prevalence after accounting for expected direct vaccine protection. We used a Bayesian hierarchical model to examine associations with vaccine coverage, time since vaccine introduction, and age at effect assessment across routine, catch-up, and non-targeted vaccination groups. XGBoost was used as a complementary, non-parametric approach. Findings Data from 11 high-income settings were included. Indirect effects increased during the first five to eight years after vaccine introduction and then remained relatively stable. Indirect effects generally decreased with increasing vaccine coverage. Patterns with age differed across vaccination groups. In the routine group, indirect effects increased during adolescence and remained positive at older observed ages. In the catch-up group, indirect effects decreased with age and approached zero or became negative after approximately age 25 years. XGBoost identified similar non-linear patterns. Interpretation Indirect protection against HPV16/18 develops gradually after vaccine introduction and varies with vaccine coverage, age, and vaccination group. This empirical approach can complement transmission models by using real-world evidence to characterise population-level indirect protection. However, making predictions outside the populations and ranges represented in the data should be done cautiously.

medRxiv
New York University (US)
Cervical Cancer and HPV Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon